SBC Medical Group Holdings Incorporated Increase (Decrease) in Accounts Payable
SBC Medical Group Holdings Incorporated (SBC) reported Increase (Decrease) in Accounts Payable of -$10.51 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2024-11-13
- SBC Medical Group Holdings Incorporated increase (decrease) in accounts payable for the quarter ending 2024-09-30 was -$10.54M, a 257.09% decline year-over-year.
- SBC Medical Group Holdings Incorporated increase (decrease) in accounts payable for the quarter ending 2024-06-30 was $17.04K, a 426.19% increase year-over-year.
- SBC Medical Group Holdings Incorporated increase (decrease) in accounts payable for the quarter ending 2024-03-31 was $16.04K.
- SBC Medical Group Holdings Incorporated increase (decrease) in accounts payable for the quarter ending 2023-12-31 was -$6.75M.
- SBC Medical Group Holdings Incorporated increase (decrease) in accounts payable for fiscal 2023 was -$35.53K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 7 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 10 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|---|
| 2024-09-30 | -$10.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$10.53M derived: sum of 2 quarters · filed 2024-11-13 | -$10.51M 10-Q · filed 2024-11-13 | -$17.26M derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2024-06-30 | $17.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-16 | $33.08K 10-Q · filed 2024-08-16 | -$6.72M derived: sum of 3 quarters · filed 2024-08-16 | -$2.86K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2024-03-31 | $16.04K 10-Q · filed 2024-05-20 | -$6.73M derived: sum of 2 quarters · filed 2024-05-20 | -$19.90K derived: sum of 3 quarters · filed 2024-11-13 | -$16.66K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-12-31 | -$6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$35.94K derived: sum of 2 quarters · filed 2024-11-13 | -$32.70K derived: sum of 3 quarters · filed 2024-11-13 | -$35.53K 10-K · filed 2024-03-19 | |||
| 2023-09-30 | $6.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $6.72M derived: sum of 2 quarters · filed 2024-11-13 | $6.71M 10-Q · filed 2024-11-13 | -$45.18K 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $3.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-16 | $409.00 10-Q · filed 2024-08-16 | |||||
| 2023-03-31 | -$2.83K 10-Q · filed 2024-05-20 | ||||||
| 2022-12-31 | $79.44K 10-K · filed 2024-03-19 | ||||||
| 2022-09-30 | $76.06K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |